Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Ligilactobacillus ruminis - : fructo-oligosaccharides |
👶
Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. The British journal of nutrition (Br J Nutr ) Vol: 88 Suppl 1 Issue Pages: S95-9 Pub: 2002 Sep Epub: Authors Bomba A , Nemcová R , Gancarcíková S , Herich R , Guba P , Mudronová D , Publication |
| Increases Ligilactobacillus ruminis - : fructo-oligosaccharides |
👶
Lactate- and acetate-based cross-feeding interactions between selected strains of lactobacilli, bifidobacteria and colon bacteria in the presence of inulin-type fructans. International journal of food microbiology (Int J Food Microbiol ) Vol: 241 Issue Pages: 225-236 Pub: 2017 Jan 16 Epub: 2016 Oct 17 Authors Moens F , Verce M , De Vuyst L , Publication |
| Increases Ligilactobacillus ruminis - : fructo-oligosaccharides |
👶
Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. The British journal of nutrition (Br J Nutr ) Vol: 86 Issue 2 Pages: 291-300 Pub: 2001 Aug Epub: Authors Kleessen B , Hartmann L , Blaut M , |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
